Regulation of SETD2, a histone methyltransferase, in advanced clear cell renal cell carcinoma (ccRCC).

被引：0
|
作者：
Thai Huu Ho
Monzon, Federico A.
Anh Hoang
Tamboli, Pheroze
Furge, Kyle A.
Dykema, Karl
Petillo, David
Teh, Bin Tean
Tannir, Nizar M.
Mien-Chie Hung
Jonasch, Eric
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, Res Inst, Houston, TX 77030 USA
[3] Van Andel Res Inst, Grand Rapids, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.368
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
368
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
    Chen, Rui
    Zhao, Wei-qing
    Fang, Cheng
    Yang, Xin
    Ji, Mei
    JOURNAL OF CANCER, 2020, 11 (11): : 3349 - 3356
  • [42] Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma (CCRCC)
    Mjones, P.
    Nordrum, I.
    Qvigstad, G.
    Sordal, O.
    Rian, L. L. Martensson
    Waldum, H. L.
    VIRCHOWS ARCHIV, 2017, 471 : S283 - S283
  • [43] Immunobiochemical profile of clear cell renal cell carcinoma (ccRCC): A preliminary study
    Vargova, Daniela
    Dargaj, Jan
    Franova, Sona
    Dohal, Matus
    Luptak, Jan
    Svihra, Jan
    Bris, Lukas
    Grendar, Marian
    Sutovska, Martina
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2023, 42 (05) : 387 - +
  • [44] The effect of SETD2 mutation (mts) on histone 3 lysine 36 trimethylation (H3K36me3) and correlation with clinical outcome in patients (pts) with metastatic clear cell renal cell carcinoma (ccRCC) enrolled in COMPARZ
    Ho, Thai Huu
    Choueiri, Toni K.
    D'Amelio, Anthony
    Hsieh, James
    De Souza, Paul L.
    Deen, Keith C.
    Langmuir, Peter B.
    Liu, Yuan
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics
    Zhang, Sihong
    Xu, Xianglai
    Wang, Yelin
    Zhu, Yanjun
    Wang, Jiajun
    Wang, Hang
    Guo, Jianming
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 597 - 608
  • [46] Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues
    Vieira de Ribeiro, Ana Julia
    Sandim, Vanessa
    Ornellas, Antonio Augusto
    Reis, Rodrigo Siqueira
    Domont, Gilberto
    Alves, Gilda
    INTERNATIONAL BRAZ J UROL, 2013, 39 (01): : 83 - 94
  • [47] Novel biomarkers and therapeutic targets in clear cell renal cell carcinoma (ccRCC)
    Meseguer Navarro, Anna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 17 - 18
  • [48] Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
    Yuan, Huairui
    Li, Ni
    Fu, Da
    Ren, Jiale
    Hui, Jingyi
    Peng, Junjie
    Liu, Yongfeng
    Qiu, Tong
    Jiang, Min
    Pan, Qiang
    Han, Ying
    Wang, Xiaoming
    Li, Qintong
    Qin, Jun
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (09): : 3381 - 3397
  • [49] The Lysine Histone Methyltransferase SETD2 Is Required for Appropriate Immunoglobulin VDJ Recombination
    Chu, S. Haihua
    Chabon, Jonathan
    Minehart, Janna
    Matovina, Chloe N.
    Zhang, Jian
    Chen, Bo-Ruei
    Callen-Moreu, Elsa
    Hung, Putzer J.
    Feng, Zhaohui
    Koche, Richard
    Liu, X. Shirley
    Chaudhuri, Jayanta
    Nussenzweig, Andre
    Sleckman, Barry
    Armstrong, Scott A.
    BLOOD, 2018, 132
  • [50] The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis
    Liu, Min
    Rao, Hanyu
    Liu, Jing
    Li, Xiaoxue
    Feng, Wenxin
    Gui, Liming
    Tang, Huayuan
    Xu, Jin
    Gao, Wei-Qiang
    Li, Li
    REDOX BIOLOGY, 2021, 43
12345